content

FDA Examines 2 Other Cancer Approvals Without Revocation

The oncology division of the FDA has recently tightened regulations for expedited approvals and emphasised the significance of patient survival data. Several businesses promptly...

COVID-19 Reinfections Are Augmented By BA.5, But Not Usually

It's not your imagination: As infections from the fast mutating BA.5 coronavirus subvariant rise throughout the United States, more people are becoming infected with...

FDA Approves Liquid Epilepsy Drug From Azurity After Denial

On the second attempt, Azurity Pharmaceuticals was able to secure an FDA nod for its zonisamide oral suspension, making it the first firm to do...

To Cure Obesity And Hunger, NICE Suggests Imcivree By Rhythm

Imcivree, also known as setmelanotide, has been recommended by the National Institute for Health and Care Excellence (NICE) in its advice for managing obesity...

Drug shortages and potential solutions to help mitigate them in the marketplace

Collaborative Solutions to Address Supply Chain Vulnerabilities and Mitigate Drug Shortages The challenges of the last several years have shined a light on the pharmaceutical...

Tower Cold Chain Secures Further Investment to Supercharge its Success

Pharmaceutical temperature-controlled specialist Tower Cold Chain has secured £6.75million in investment, to reinforce the business as the leader in robust, reliable, and reusable cold...

AARDEX® Group and BIOCORP Recruited by Trials@Home – Decentralized Clinical Trial Centre of Excellence

Following the launch of their global collaboration to support medication adherence in different fields last year, Belgium-based AARDEX GROUP, the leader in tools for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read